James George Robinson

James George Robinson discloses dealings in 2 companies, chiefly Nymox Pharmaceutical Corp and Allied Corp. Between 4 January 2016 and 25 April 2023, the trades on record add up to 16 filings.

The open-market record is one-sided, with 16 purchases worth €49k and not one sale. No amount is published for 13 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2023 to date brings 3 purchases and no sales.

Half of the purchases are above €16k and half below. Across 15 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 26 June 2023 came the latest disclosure, an open-market purchase for €16k in Nymox Pharmaceutical Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.